AC Immune (ACIU) Restructuring Costs (2021 - 2025)

AC Immune (ACIU) posted quarterly Restructuring Costs of $15014.0 for Q4 2025, up 102.57% quarter-over-quarter from -$583801.1 in Q3 2025.

Analysis

AC Immune (ACIU) Restructuring Costs (2021 - 2025) Analysis & Trends

AC Immune (ACIU) has reported Restructuring Costs for 2 consecutive years, with $15014.0 the latest figure, recorded in Q4 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn
10	AC Immune	285.13 Mn	285.13 Mn	-

Historic Data

Download Data